Discovery

Monotype Unveils Modern Branding Insights at SXSW 2024 with Creative Powerhouses, Pantone, Canva, and Getty Images

Retrieved on: 
Tuesday, March 12, 2024
Discovery, Element, EBay, Q&A, Partnership, SXSW, Getty Images, Dentsu, AI, Futurist, Senior, Content, Creativity, WeTransfer, Neuron, Ingredient

Monotype hosts SXSW-official panel, "The Ingredients for Building a Modern Brand," alongside speakers from Pantone, Canva, and Getty Images on March 14.

Key Points: 
  • Monotype hosts SXSW-official panel, "The Ingredients for Building a Modern Brand," alongside speakers from Pantone, Canva, and Getty Images on March 14.
  • Leaders from dentsu, eBay, Neurons, and WeTransfer will join Monotype for a live recording of the Creative Characters podcast on March 13.
  • WOBURN, Mass., March 12, 2024 /PRNewswire/ -- Monotype , a global leader in type and technology, will be presenting a creator-track panel at SXSW 2024 on Thursday, March 14, at 11:30 a.m. CT titled, "The Ingredients for Building a Modern Brand," in partnership with design leaders from Pantone, Canva, and Getty Images.
  • "This event will bring together storytellers, designers, and futurists to discuss pressing challenges surrounding modern branding and the future of creative work."

Monotype Unveils Modern Branding Insights at SXSW 2024 with Creative Powerhouses, Pantone, Canva, and Getty Images

Retrieved on: 
Tuesday, March 12, 2024
Discovery, Element, EBay, Q&A, Partnership, SXSW, Getty Images, Dentsu, AI, Futurist, Senior, Content, Creativity, WeTransfer, Neuron, Ingredient

Monotype hosts SXSW-official panel, "The Ingredients for Building a Modern Brand," alongside speakers from Pantone, Canva, and Getty Images on March 14.

Key Points: 
  • Monotype hosts SXSW-official panel, "The Ingredients for Building a Modern Brand," alongside speakers from Pantone, Canva, and Getty Images on March 14.
  • Leaders from dentsu, eBay, Neurons, and WeTransfer will join Monotype for a live recording of the Creative Characters podcast on March 13.
  • WOBURN, Mass., March 12, 2024 /PRNewswire/ -- Monotype , a global leader in type and technology, will be presenting a creator-track panel at SXSW 2024 on Thursday, March 14, at 11:30 a.m. CT titled, "The Ingredients for Building a Modern Brand," in partnership with design leaders from Pantone, Canva, and Getty Images.
  • "This event will bring together storytellers, designers, and futurists to discuss pressing challenges surrounding modern branding and the future of creative work."

Basware launches tool to deliver a completely touchless invoice process

Retrieved on: 
Tuesday, March 12, 2024
Discovery, Automation, ROI, AP, Organization, TIP, Workflow, System, Bookkeeping

CHARLOTTE, N.C., March 12, 2024 /PRNewswire/ -- Basware, a global leader in AP automation and invoice processing, has launched its Touchless Invoice Processing (TIP) Discovery dashboard, marking yet another milestone in Basware's mission to achieve 100% touchless processes. The tool allows customers to analyze manual invoice handling rates, shedding light on where touchless processes break down into manual touches.  

Key Points: 
  • The tool allows customers to analyze manual invoice handling rates, shedding light on where touchless processes break down into manual touches.
  • Basware has launched its TIP Discovery dashboard, which offers a clear view into each phase of the invoice process, enabling customers to monitor the touchless rate of their selected process.
  • With Basware's Touchless Invoice Processing Discovery dashboard, we are shining a bright light on where touchless processes break down into manual touches.
  • The tool will push businesses towards future-proofing their financial operations and furthering 100% touchless invoice processing."

Basware launches tool to deliver a completely touchless invoice process

Retrieved on: 
Tuesday, March 12, 2024
Discovery, Automation, ROI, AP, Organization, TIP, Workflow, System, Bookkeeping

LONDON, March 12, 2024 /PRNewswire/ -- Basware, a global leader in AP automation and invoice processing, has launched its Touchless Invoice Processing (TIP) Discovery dashboard, marking yet another milestone in Basware's mission to achieve 100% touchless processes. The tool allows customers to analyze manual invoice handling rates, shedding light on where touchless processes break down into manual touches.  

Key Points: 
  • The tool allows customers to analyze manual invoice handling rates, shedding light on where touchless processes break down into manual touches.
  • Basware has launched its TIP Discovery dashboard, which offers a clear view into each phase of the invoice process, enabling customers to monitor the touchless rate of their selected process.
  • With Basware's Touchless Invoice Processing Discovery dashboard, we are shining a bright light on where touchless processes break down into manual touches.
  • The tool will push businesses towards future-proofing their financial operations and furthering 100% touchless invoice processing."

CACTUS partners with PNAS to make the journal's high-quality research accessible through R Discovery

Retrieved on: 
Monday, March 11, 2024
Nexus, Discovery, CACTUS, Culture, Database, University, Partnership, Society, Research, PNAS, Conference proceedings, National academy, NAS, Social, Literature, Pharmaceutical industry

This will make PNAS' high-quality research accessible to researchers through R Discovery, the highest-rated literature search and research reading platform by CACTUS.

Key Points: 
  • This will make PNAS' high-quality research accessible to researchers through R Discovery, the highest-rated literature search and research reading platform by CACTUS.
  • Leveraging cutting-edge AI technology, R Discovery is dedicated to enriching the research discovery and reading experience for researchers.
  • Ms. Diane Sullenberger, Executive Editor of PNAS and PNAS Nexus, notes: "Our partnership with Cactus Communications signifies our shared vision to make PNAS research universally accessible through R Discovery.
  • This partnership marks a significant milestone for R Discovery, expanding its repository and solidifying its position as a leading platform for on-the-go research discovery.

ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University

Retrieved on: 
Monday, March 11, 2024
Discovery, Harvard Medical School, Research, Neurology, Ono Pharmaceutical, Drug discovery, Patient, Harvard University, Senior, OTD, Pharmaceutical industry

OSAKA, Japan, March 11, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University (Cambridge, MA, USA; "Harvard") aiming at validating novel therapeutic targets.

Key Points: 
  • OSAKA, Japan, March 11, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University (Cambridge, MA, USA; "Harvard") aiming at validating novel therapeutic targets.
  • Working together with Harvard's Office of Technology Development (OTD), Ono will support and fund research projects that are jointly selected.
  • With the combined expertise and resources of both Ono and Harvard, this strategic alliance will promote our innovative drug discovery efforts.
  • "We are pleased to work together with Harvard University, a leading institution developing cutting-edge technologies and advancing research through strategic alliances such as this one," stated Toichi Takino, Senior Executive Officer / Executive Director, Discovery & Research at Ono Pharmaceutical.

Anima Biotech to Present at RNA Leaders Europe Congress

Retrieved on: 
Thursday, March 7, 2024
Gal, Biology, RNA Biology, Tech, Congress, RNA, Messenger, Discovery, Business development

BERNARDSVILLE, N.J., March 07, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, today announced their participation in the upcoming RNA Leaders Europe Congress taking place on March 13th – 14th, 2024 in Basel, Switzerland.

Key Points: 
  • BERNARDSVILLE, N.J., March 07, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, today announced their participation in the upcoming RNA Leaders Europe Congress taking place on March 13th – 14th, 2024 in Basel, Switzerland.
  • During the congress, Anima’s Vice President of Business Development, Gal Gur, Ph.D., will participate in two roundtable sessions, both focused on the topic of, “Target selection – lessons learned from small molecules RNA Biology,” to discuss her learnings from working on target selection in the mRNA biology space.
  • The sessions are taking place on March 14th at 9:05 AM and 9:50 AM CET.
  • The RNA Leaders Europe Congress program features scientific tracks covering in-depth development strategies, trends, and technologies across the entire long and small RNA spectrum.

Quanta Therapeutics Announces Late-Breaking Presentation of QTX3544, a G12V-preferring multi-KRAS inhibitor, at AACR Annual Meeting

Retrieved on: 
Tuesday, March 5, 2024
Quanta, SAN, Therapy, AACR, Discovery, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company pioneering targeted therapies to treat RAS-driven cancers, today announced it will give a late-breaking poster presentation of QTX3544 at the American Association for Cancer Research (AACR) Annual Meeting being held April 5-10, 2024, in San Diego, California.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company pioneering targeted therapies to treat RAS-driven cancers, today announced it will give a late-breaking poster presentation of QTX3544 at the American Association for Cancer Research (AACR) Annual Meeting being held April 5-10, 2024, in San Diego, California.
  • QTX3544 is a KRASG12V-preferring multi-KRAS inhibitor with favorable preclinical properties, including potency, selectivity, and oral bioavailability.
  • Quanta Therapeutics' allosteric approach has the potential to target the majority of KRAS mutations with a robust mechanism of action addressing multiple conformations of KRAS.
  • Title: Discovery and characterization of QTX3544, a potent, selective, and orally bioavailable allosteric G12V-preferring multi-KRAS inhibitor

Discovery Lithium’s 2023 Exploration Program Sets the Stage for 2024

Retrieved on: 
Friday, March 1, 2024
Lithium, Bureau Veritas, Weather, QP, CS, OTC, Mineral, News, FRA, LCT, Lidar, Discovery, Metal, DCLI, SGS, National instrument, Pathfinder, National Instrument 43-101, Caesium, ICP-MS, WKN, Tantalum, Laboratory

VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) -- Discovery Lithium Inc. (CSE: DCLI) (OTC: DCLIF) (FRA: Q3Q0) (WKN: A3EFKA) (the “Company” or “Discovery Lithium”), a Canadian exploration company focused on advancing domestic energy freedom through regional lithium discovery, is pleased to provide the following summary of its recently concluded 2023 exploration program in the province of Quebec.

Key Points: 
  • VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) -- Discovery Lithium Inc. (CSE: DCLI) (OTC: DCLIF) (FRA: Q3Q0) (WKN: A3EFKA) (the “Company” or “Discovery Lithium”), a Canadian exploration company focused on advancing domestic energy freedom through regional lithium discovery, is pleased to provide the following summary of its recently concluded 2023 exploration program in the province of Quebec.
  • All outstanding results from 2023 have been received and are being interpreted by Discovery Lithium’s exploration team.
  • Company Technical Director Dr. Jacob Verbaas, P. Geo states, “We expect 2024 to be an exciting year for the Company.
  • The Phase 2 exploration programs are expected to outline drill targeting and drilling in the latter half of 2024.

tvScientific Announces $9.4 Million Convertible Note led by S4S Ventures to Accelerate Growth and Development

Retrieved on: 
Wednesday, February 28, 2024
Social media, CPA, Netflix, Television, Smart TV, Connected, MoneyGram, ROI, General partnership, MMM, EMarketer, ABC, BDMI, Discovery, Entrepreneurship, Advertising, Meta, NBC, CTV, Partner (business rank), The Walt Disney Company, Fender, CBS, Partnership, Mobile phone

With tvScientific, advertisers can buy and execute performance CTV campaigns with major inventory partners, including Paramount+, Hulu, Discovery, ABC, CBS and NBC.

Key Points: 
  • With tvScientific, advertisers can buy and execute performance CTV campaigns with major inventory partners, including Paramount+, Hulu, Discovery, ABC, CBS and NBC.
  • This opens up an entirely new cohort of advertisers for TV publishers” said Jason Fairchild, Co-Founder and CEO of tvScientific.
  • “Google and Meta have fueled meteoric growth in advertising precisely because of their precision targeting and outcome-based measurement.
  • Consumers now dictate how they want to consume media and this partnership aligns with the evolving preferences of today's audiences."